相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis
Abhishek Deshpande et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study
Hamed Khalili et al.
BRITISH MEDICAL JOURNAL (2012)
The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studies
Kevin P. Bliden et al.
AMERICAN HEART JOURNAL (2011)
Withdrawing PPI Therapy After Healing Esophagitis Does Not Worsen Symptoms or Cause Persistent Hypergastrinemia: Analysis of Dexlansoprazole MR Clinical Trial Data
David C. Metz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies
Saowanee Ngamruengphong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Prescribing proton pump inhibitor and clopidogrel together: current state of recommendations
Neena S. Abraham
CURRENT OPINION IN GASTROENTEROLOGY (2011)
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
Edward Sheen et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Clopidogrel and Proton Pump Inhibitors Influence of Pharmacological Interactions on Clinical Outcomes and Mechanistic Explanations
Udaya S. Tantry et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis
Guillaume Cayla et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Dyspeptic Symptom Development After Discontinuation of a Proton Pump Inhibitor: A Double-Blind Placebo-Controlled Trial
Anna Niklasson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women Results From the Women's Health Initiative
Shelly L. Gray et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Amy Linsky et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
Neena S. Abraham et al.
CIRCULATION (2010)
Adverse effects of proton pump inhibitor drugs: clues and conclusions
Denis M. McCarthy
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss
Laura E. Targownik et al.
GASTROENTEROLOGY (2010)
Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients
Douglas A. Corley et al.
GASTROENTEROLOGY (2010)
Safety of Proton Pump Inhibitor Exposure
Yu-Xiao Yang et al.
GASTROENTEROLOGY (2010)
Drug-induced acute interstitial nephritis
Mark A. Perazella et al.
NATURE REVIEWS NEPHROLOGY (2010)
Clopidogrel with or without Omeprazole in Coronary Artery Disease.
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint
Helge L. Waldum et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users
A. M. Dries et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to Treat
Kenneth E. L. McColl et al.
GASTROENTEROLOGY (2009)
Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy
Christina Reimer et al.
GASTROENTEROLOGY (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
Jean-Philippe Collet et al.
LANCET (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors
B. I. Hirschowitz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Proton-pump inhibitor use and the risk for community-acquired pneumonia
Monika Sarkar et al.
ANNALS OF INTERNAL MEDICINE (2008)
Association between proton pump inhibitors and respiratory infections: A systematic review and meta-analysis of clinical trials
Nabil Sultan et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Use of proton pump inhibitors and risk of osteoporosisrelated fractures
Laura E. Targownik et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Severe hypomagnesaemia in long-term users of proton-pump inhibitors
T. Cundy et al.
CLINICAL ENDOCRINOLOGY (2008)
American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease
Peter J. Kahrilas et al.
GASTROENTEROLOGY (2008)
Proton pump inhibitor use and risk of hip fractures in patients without major risk factors
James A. Kaye et al.
PHARMACOTHERAPY (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Systematic review: proton pump inhibitor-associated acute interstitial nephritis
F. Sierra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Use of proton pump inhibitors and the risk of community-acquired pneumonia - A population-based case-control study
Sinem Ezgi Gulmez et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Systematic review of the risk of enteric infection in patients taking acid suppression
Jennifer Leonard et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Long-term proton pump inhibitor therapy and risk of hip fracture
Yu-Xiao Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture
P. Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
A case-control study on adverse effects:: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults
RJ Valuck et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs
RJF Laheij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity
K Zedtwitz-Liebenstein et al.
CRITICAL CARE MEDICINE (2002)
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids
J Theisen et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2000)
分享论文
